Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Fitch revises rating of India Infoline Finance Ltd

Posted On: 2020-03-28 20:46:38


The international credit rating agency, Fitch Ratings has revised / changed the Long-Term Issuer Default Rating (IDR) to "B+" from "BB-" assigned to India Infoline Finance Limited ("India Infoline"), a material subsidiary of IIFL Finance Ltd.

Fitch Ratings has also revised/changed the rating assigned to India Infoline's USD1 billion medium-term note (MTN) programme to "B+" from "BB-".

The downgrade and RWN reflect our expectation of increased pressure on IIFL's asset quality, which will weigh on its funding and liquidity. SME loans, developer financing and capital market finance, which Fitch perceives to be of higher risk in current conditions, make up 40%-45% of IIFL's loan portfolio. Another 7% of loans were extended to microfinance at end-December 2019, which may also be more vulnerable in a downturn as borrowers are typically less financially resilient.

We believe that IIFL's exposure to these risker loan segments renders it more susceptible to shifts in market confidence, and in the current environment outweighs the relative resilience of its home loans and gold loans, which make up close to half of the loan book.

IIFL's IDR also reflects its moderate franchise in India's NBFI sector and experienced management team, as well as its appetite for high growth and tolerance for elevated leverage.

We believe IIFL's funding and liquidity access remains weaker than that of other Fitch-rated peers and more vulnerable in times of heightened risk aversion. This is despite the funding mix remaining stable and adequately balanced at present. The liquidity position and contingent liquidity coverage remained broadly stable at end-February 2020 with net positive liquidity gaps and adequate contingent liquidity coverage of upcoming liabilities. However, the company continues to be more reliant on loan assignments and securitisation to fund its portfolio, and existing liquidity buffers can be eroded if the sector's funding strains are prolonged.

A deterioration in asset quality, signs of more constrained funding access, narrowed or negative liquidity gaps or reduced liquidity buffers would lead to negative rating action. Leverage increasing beyond 7x (December 2019: 5.1x) would also add to pressure on the ratings.

The ratings may be upgraded when there is greater evidence that IIFL is able to maintain and improve its funding and liquidity profile without over-reliance on asset sales and securitisation, even as current market constraints continue. This is provided that the company demonstrates reasonably steady collections on its developer financing, SME and microfinance portfolios throughout the period.

Shares of IIFL Finance Limited was last trading in BSE at Rs.79 as compared to the previous close of Rs. 75.45. The total number of shares traded during the day was 49826 in over 575 trades.

The stock hit an intraday high of Rs. 79.2 and intraday low of 74.25. The net turnover during the day was Rs. 3904705.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

RPG Life Sciences Ltd Q4 net profit at Rs. 2.98 crore

Kirloskar Brothers Ltd Q4 consolidated net profit at Rs. 23 crore

Silver Lake and Co-Investors to invest additional Rs. 4,546.80 crore in Jio Platforms

Saurashtra Cement Ltd takes annual maintenance shutdown at Ranavav factory

TIMKEN India Ltd board recommends dividend of Rs. 50

RPG Life Sciences Q4'FY 20 revenue up by 29%

Infibeam Avenues announces Fourth Quarter and Fiscal Year 2020 Results

L&T reports consolidated earnings for Q4, FY2020

Refex Industries Limited board to finalize rights issue terms

Greaves accelerates performance in new business initiatives with 21% contribution in FY20

TIMKEN India Ltd Q4 PAT at Rs. 61.26 crore

Natural Capsules Ltd posts Rs. 0.11 crore in Q4 FY20

SMS Pharmaceuticals Ltd Q4 PAT drops to Rs. 6.32 crore

Sumitomo Chemical India Ltd Q4 consolidated PAT at Rs. 22.90 crore

L&T Board recommends Final Dividend of Rs. 8

Natural Capsules Ltd Board approves dividend of Rs. 0.60

Jyothy Labs Ltd Q4 FY20 consolidated PAT at Rs. 28.80 crore

Aditya Birla Capital Ltd reports consolidated Q4 PAT of Rs. 143.67 crore

PPAP Automotive Ltd reports consolidated PAT of Rs. 5.85 crore in Q4 FY20

CG-VAK Software & Exports Ltd Q4 consolidated PAT at Rs. 1.28 crore

Exide Industries Ltd reports lower top line in Q4 FY2020

Gateway Distriparks Ltd announces FY2020 performance

CG-VAK Software and Exports Ltd board recommends dividend of Rs. 0.75 for FY20

Infibeam Avenues Ltd to acquire Cardpay Technologies Pvt Ltd

Pfizer Ltd Board to consider FY20 results & Final Dividend on June 15, 2020

Sumitomo Chemical India Ltd board declares dividend of Rs. 0.55

IRB InvIT Fund board declares 4th distribution of Rs. 1.80 for FY2020

Apollo Pipes Ltd launches water storage tank

Gujarat Gas Ltd Q4 consolidated PAT at Rs. 250.46 crore

Dr. Kiran Mazumdar-Shaw from India named EY World Entrepreneur Of The Year™ 2020

Alkem Laboratories Ltd Board approves final dividend of Rs. 3

SBI - Q4 / FY2020 Highlights

Mahindra to plant a tree for every service availed digitally on its With You Hamesha app

V-Guard presents new range of AIKIDO air coolers to beat the heat

IndiGo operates flight chartered by NALSAR to transport 174 migrant workers

Maruti Suzuki sells over 1 lakh factory fitted CNG vehicles - Highest ever in a fiscal

Alkem Laboratories Ltd Q4FY20 consolidated PAT at Rs. 188.77 crore

Lasa Supergenerics Ltd Q4 FY2020 PAT at Rs. 2.58 crore

Saregama India Ltd Board recommends dividend of Rs. 1.50

SBI Q4 FY20 consolidated PAT at Rs. 6909.95 crore

Suven Life Sciences Ltd reports loss of Rs. 25.55 crore in Q4 FY20

Saregama India Ltd Q4 consolidated PAT at Rs. 15.81 crore

Snowman reports optimistic results in pessimistic market outlook backed by Strong Fundamentals and Robust Business Model

Zydus Cadila receives final approval from USFDA for Atazanavir Capsules

Cheviot Company Ltd Q4 PAT falls to Rs. 3.50 crore

JSW Steel Ltd allots 10,000 NCDs

Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients

Maruti Suzuki commissions 5 MW carport style photovoltaic solar power plant in Gurugram

Hexaware Technologies Ltd board to consider voluntary delisting on June 12, 2020, stock locked in upper circuit

TCS Wins 2020 SAP® Pinnacle Award







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019